Hoechst-Roussel intermittent claudication consumer ad
Executive Summary
The firm began running its revised institutional television ad campaign for intermittent claudication the week of Dec. 23. The ad is scheduled to run two-three weeks. A similar ad appears in print media, including the New York Times, USA Today, and TV Guide. The television ad is a revision of a previous Hoechst ad to which FDA objected. FDA asserted that the earlier ad's emphasis on availability of a drug (the unspecified Trental) constituted an advertisement for a specific Rx drug ("The Pink Sheet" Oct. 21, T&G-5).